Operating room equipment market size is expected to reach USD 48.50 billion by 2025

The global operating room equipment market size was valued at USD 26.24 billion in 2016 and is expected to reach USD 48.50 billion by 2025, at CAGR of 7.2%. Growing demand for improved medical facilities coupled with transition from conventional to state-of-the-art operation theaters is anticipated to escalate the operating room equipment market over the forecast period. Technological transformations, infrastructural development and high investments in the medical devices by hospital and healthcare centers are expected to spur the medical equipment demand over the forecast period. Development of hybrid operating rooms has prompted the installation of multi-purpose equipment, enabling automated results coupled with high operational efficiency, providing ample space for the introduction of high end equipment.

High occurrence of medical disorders among geriatric population along with the prevalence life threatening diseases is anticipated to fuel advanced operating equipment demand. Availability of advanced surgical tools and high prevalence of chronic disorders or diseases is also anticipated to escalate product demand over the forecast period. Key challenge faced by the industry includes the high cost associated, which is expected to hamper introduction of these devices in hospitals. Lack of knowledge and skilled manpower required to handle complex devices is also expected to hinder market growth over the forecast period.  Rise in number of high-end operating rooms accompanying advanced equipment along with increasing number of ASC (Ambulatory Surgical Center) is anticipated to substantially drive the level of innovation among manufacturers instigating them to provide latest technologies.

Browse full research report:

https://www.millioninsights.com/industry-reports/operating-room-equipment-market

Advanced and efficient operating tables, surgical booms, operating room integration systems, operating room lights, surgical headlights, surgical light sources and surgical imaging display forms an integral part of the new age hybrid theaters. Further, anesthesia equipment, electrosurgical generators, defibrillators, respiratory ventilators, endoscopy equipment, vital sign monitors, pneumatic tourniquet, infusion pumps, surgery microscopes, medical stainless steel, patient warmers, suction pumps, hospital stretchers, medical warmers, hospital stretchers, autoclaves & sterilizers, sequential compression devices and vaporizers & accessories contributes essential functionalities to an operating theater.

Integration of non-surgical and surgical equipment in the hybrid operating rooms including patient monitoring, diagnostics and radiology among others coupled with imaging techniques such as MRI scanners, CT scanners and C- arm provides better ease and flexibility to the specialist to perform the task. Installation of hybrid operation rooms largely reduces the hustle of transferring a patient from the operation theater to the scanning center. This greatly automates the work efficiencies and results in better patient care, thereby adding to the business value.

Operating rooms presently require high-definition fixed imaging and video equipment, enabling information from all over the hospital at the surgeon’s fingertip, and are expected to drive the industry demand over the forecast period. The industry is witnessing a growing trend towards installation of larger imaging systems. Operating rooms today are an economic engine for any medical facility, and accounts for more than 60% of the revenue. Further, hospitals often face an increasing drive for patient oriented effectiveness. Hospitals need to focus on creating value for the patient with the installation of state-of-the-art equipment with a combination of optimally trained medical expert. In addition, optimizing the operation environment helps enhance surgeon performance, and is thereby expected to drive the operating equipment market over the forecast period.

Europe and North America are expected to emerge as the largest markets due to existence of well-established medical sector with the presence of technologically advanced medical systems. The regions are expected to witness significant growth due to the upgradation of technology with advanced automated systems and rise in number of hospitals. Evolving medical industry in the Asia Pacific region including India, Thailand, Malaysia and South Korea due to rise in population encourages the medical sector to install high-end medical facilities and technologies at low costs.

Major players in the market include Steris Corporation, Hill-Rom Holding Inc., GE Healthcare, Phillips Healthcare, Stryker Corporation, Mizuho OSI, Getinge Group, Dragerwerk, Medtronic Inc, Eschmann Equipment, Karl Storz GmBH & Co. KG, Skytron, NDS Surgical Imaging, Berchtold Corporation, Trumpf GmBH + Co. KG, Creative Heath Tech Pvt. Ltd., Siemens Healthcare.

To get free request sample:

https://www.millioninsights.com/industry-reports/operating-room-equipment-market/request-sample

The healthcare market is majorly driven by the cheap availability of highly efficient systems and tags

Industry Insights

Global RFID in healthcare market was valued at USD 646.7 million in 2014 and is expected to reach over USD 3.89 billion over the next seven years. Key influences attributing to this rapid growth include growing occurrences of theft and loss of different medical devices which result in high losses to the pharmacies and hospitals. Healthcare services use radio frequency identification (RFID) and real-time location systems (RTLS) to track, identify, monitor patients, locate, visitors, assets, equipment and staff. Know that, how of these technologies aid in improving safety, enhancing the quality of care, reducing financial waste, and fostering patient satisfaction.

The healthcare market is majorly driven by the cheap availability of highly efficient systems and tags. Improper storage systems and careless handling in pharmaceutical stores have led to rising number of stock outs and expiration of medicines. This, in turn, may impact in loss of revenue and reputation which is anticipated to encourage better usage in the foreseeable future.

Furthermore, one of the high impact rendering drivers for the growth of this market is the development and rising usage of Kanban systems in order to achieve lean inventory. RFID Kanban systems allow organizations to lessen their inventory value by 15-35% according to a study shown by Stanley Healthcare. In addition, with inventory reduction by 50%, the inventory replenishment expenses can be condensed down to a total expenditure of just 5% of overall. Furthermore, these changes are anticipated to cut down on the storage space by 22%. As a result, storage costs are reduced substantially subsequently decreasing energy costs as well.

Browse full research report:

https://www.millioninsights.com/industry-reports/rfid-in-healthcare-market

Implementation of advanced Kanban systems in existing hospital inventory management and timely placement of orders to the supplier directly for requisite medical devices and medication is expected to encourage hospitals and pharmacies to incorporate these systems. RFID systems find widespread applications in the healthcare sector and have an increasing penetration in areas including infection control, injection safety, tracking prescription drugs and radiology. These systems are anticipated to improve market capitalization in coming seven years. For instance, Sanraku Hospital collaborated with BayNexusin an attempt to manage their medical equipment efficiently. Which also, to reduce time taken to inspect medical conditions, Wake Forest Baptist Medical Center integrated RFID tags on the closures of x-ray vests.

Product Insights

On the basis of product type, RFID systems and tags are segmented into two main products. In 2014, RFID systems contributed to over 55% of the overall market share. Key factors contributing to this large share includes high penetration of these devices in the market owing to better awareness levels regarding the advantages of RFID devices such as their ability to embed into existing hospital ERP software systems and reduction in overall operational costs. Systems are further categorized as pharmaceutical tracking, asset tracking, blood monitoring and patient tracking.

In 2014, the pharmaceutical segment constituted for the largest share and is projected to emerge as the dominant market leader in the next seven years. RFID tags cost approximately 4-6 cents which turn to be cost effective and may render as a high impact driver for market growth in the next seven years. Additionally, tags market is also sub divided on the basis of their end-use in varies departments including pharmaceutical tracking tags, asset tracking tags, blood monitoring tags and patient tracking tags.

Download free request sample:

https://www.millioninsights.com/industry-reports/rfid-in-healthcare-market/request-sample

Regional Insights

Asia-Pacific, North America, Latin America, MEA and Europe are key regional markets. In 2014, North America was the dominant market player which captured over 50% of the overall share. Key factors accrediting to its large share include the existence of developed healthcare infrastructure together with high awareness levels about the advantages of these systems.

Further, in November 2013, U.S. president entered into a contract with The Drug Quality and Security Act (DQSA) that outlines essential steps to form an interoperable and electronic system that could trace and ascertain prescription drugs while they are distributed in the United States. The usage of RFID tags and systems in the U.S. is expected to rise owing to the emergence of aforementioned steps over the forecast period.

However, Asia Pacific is projected to grow at a rapid over the forecast period. New multinational hospital chains, continuously improving healthcare infrastructure and favourable government initiatives in the region will considerably propel growth in Asia Pacific market.

Market Share Insights

Key performers functioning in the industry include Terson Solutions, Log Tag, Solstice Medical LLC, Mobile Aspects Inc, Logi Tag, Wave Mark, Hurst Green Plastics Ltd., Pepperl+Fuchs, Tagsys RFID Group, Metra Tec GmbH, Wurth Group, Bollhoff Group, Stanley Innerspace, Brooks Automation, Grifols and Datelka.

Diabetes is a chronic disorder related with defects in the secretion of insulin from the hyperglycemia

The global Diabetic Retinopathy Market size is likely to reach USD 10.08 billion by 2025. Diabetes is a chronic disorder related with defects in the secretion of insulin from the hyperglycemia or pancreas associated to insulin resistance which eventually leads to long term multi-organ problems of kidneys, eye, blood vessels, nerves and heart.

Factors, such as increasing aged population, up-gradation of healthcare infrastructure, rising demand for initial detection systems, technological advancements, uncontrolled glucose levels and ignorance towards treatment, and increasing research activities towards developing advanced products are likely to drive the diabetic retinopathy industry in the forthcoming period.

On the other hand, lack of skilled professionals, presence of low-income groups, high cost associated with the treatment and poor availability to healthcare services are anticipated to hinder diabetic retinopathy market growth in future. However, prolonged undiagnosed diabetes is likely to create lucrative opportunities for the market. Diabetic retinopathy industry is anticipated to expand at a CAGR of 6.3% in the upcoming period as the scope, product types and its applications are increasing across the globe.

Browse full research report:

https://www.millioninsights.com/industry-reports/diabetic-retinopathy-market

Diabetic retinopathy market is segmented by type, treatment type, indications, end user and geography. The market is segmented by type as Proliferative Diabetic Retinopathy and Non-proliferative diabetic retinopathy. The “Non-proliferative diabetic retinopathy” segment accounted for a prominent share in the market. It is likely to witness substantial growth in the years to come. The key factors that could be attributed to the growth of market includes presence of huge number of patients (less than 10 years of diabetic history) and increased occurrence of diabetes.

Based on treatment type, the diabetic retinopathy industry is segmented by Vitrectomy, Steroid Implants, Anti VEGF Drug and Laser Surgeries. The “Anti VEGF Drug” segment accounted for a prominent share in the market. It is likely to witness a substantial growth in the years to come. The key factors that is could be attributed to the growth of market include mild to moderate cases of non-proliferative DR treatment, and better treatment and high applicability and faster recovery of these drugs in treatment of initial diagnosis.

The diabetic retinopathy market is segmented based on the end user as Ambulatory Surgical Centers, Hospitals and Ophthalmic Clinics. Based on indications, the market of diabetic retinopathy is segmented as Proliferative Diabetic Retinopathy (PDR) and Non-Proliferative Diabetic Retinopathy (NPDR) (Severe, Moderate and Mild).

North America is a leading region in the market. It is likely to maintain a dominance in the forecast period owing to factors, such as a large number of aged populations, increase in occurrence of diabetic retinopathy patients in the region, increasing healthcare infrastructure and rising health awareness among population. In addition, North America is followed by Asia-Pacific region owing to changing lifestyle of people in the region, surge in diabetic population, increase in funding and support provided by the government.

Key players operating in the diabetic retinopathy industry include Alimera Science, Abbott Laboratories, Allergan plc, Bayer AG, Ampio Pharmaceuticals., Novartis International AG, F. Hoffmann-La Roche, Pfizer, Valeant Pharmaceutical, Regeneron Pharmaceuticals Inc., KOWA Company, Ltd., Boehringer Ingelheim GmbH, ThromboGenics NV., and BCN Peptides S.A. The leading companies are involved in partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Download free request sample:

https://www.millioninsights.com/industry-reports/diabetic-retinopathy-market/request-sample

Rise in government initiatives to create awareness pertaining to contamination level in drugs & formulations coupled with R&D analysis

The global X-Ray photoelectron spectroscopy market is likely to cross USD 712.4 million owing to rise in demand for medical research, minimal medication error and technological progress. The market is driven by factors such as rise in government initiatives to create awareness pertaining to contamination level in drugs & formulations coupled with R&D analysis is expected propel the market growth. Rise in government regulations and certifications emphasizing drug safety for various raw materials and formulation are expected to contribute to the X-Ray photoelectron spectroscopy industry in the forthcoming period. However, significant costs of set up for new market entrants are likely to create hindrances in the market growth in the forecast period up to 2025.

Browse full research report:

https://www.millioninsights.com/industry-reports/x-ray-photoelectron-spectroscopy-xps-market

X-Ray photoelectron spectroscopy also termed as electron spectroscopy for chemical investigation is widely used to investigate chemical proportion of surfaces. The proliferated use of XPS in investigative laboratories across the globe acts as a problem solving capability of the technique. The capacity to discover the initial atomic layers to assign chemical states to the discovered atoms renders X-Ray photoelectron spectroscopy to be an optimal addition to any analytical theory.

X-Ray photoelectron spectroscopy market is segmented by use, application, and geography. Use segment dominates the market scenario owing to rise in diverse applicability such as element detection, density estimation, contamination detection and empirical formulation. Element detection accounts for significant market share during the forecast period owing to efficiency and accuracy offered. Contamination detection accounts for second position in the market share due to certain use of XPS for organic as well as inorganic contaminants. Rise in demand for systems & technologies to offer accurate results is additionally likely to contribute to the market growth in the forecast period.

Geographical segmentation for X-Ray photoelectron spectroscopy industry spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America X-Ray photoelectron spectroscopy market is expected to dominate the global market scenario owing to rise in application for XPS for medical research, existing technological evolution.

Favorable reimbursement is another factor adding to the X-Ray photoelectron spectroscopy market growth in the forecast period. Asia-Pacific’s X-Ray photoelectron spectroscopy industry is likely to contribute to the market growth due to wide presence of manufacturers and availability of favorable market conditions. The key players in the X-Ray photoelectron spectroscopy market include Thermo Fisher Scientific, Kratos Analytical, Evan Analytical Group (EAG), Intertek, V G Scienta, Yokogawa, Kett and Mitsubishi Electric.

Download free request sample:

https://www.millioninsights.com/industry-reports/x-ray-photoelectron-spectroscopy-xps-market/request-sample

Robot and power assisted medical tools introduction is estimated to further enhance industry growth

Global surgical equipment/instruments market was valued at USD 10.5 billion in 2016 and is expected to reach a value of USD 20.3 billion by 2025. Global surgical equipment market is expected to experience brisk growth due to rise in demand for nominal hostile surgeries over the forecast period. Novel technologies such as robot and power assisted medical tools introduction in recent past is estimated to further enhance industry growth.

Surgical tools are medicinal devices that serve some specific need during any surgery. These devices allow the physical alteration of biological tissue to deliver access to internal body parts. This equipment’s are tools that are used to complete functions such as suturing cutting, holding, dissecting, retracting, or grasping. These instruments are hand handled or sometimes power based robotic devices. Technologies viz. robotic based medical devices and minimally invasive medical equipment development are presumed to be key driving factors for the surgical equipment market. Rise in aged population coupled with increase in medical processes is estimated to fuel the growth over the forecast period. Modernization in operating devices which provide improved & better outcomes along with increase in demand for less complicated procedures are some important success factors that are expected to contribute for the global growth over the six year period. Growth in adaptation and approval for arthroscopy and minimal invasive procedures usages due to convenience is expected to further complement the market growth.

In-Depth research report on Surgical Equipment Market :

https://www.millioninsights.com/industry-reports/circuit-breaker-fuse-relay-market

Growth in demand for advanced twisted healing materials such as medical adhesives, glues, high-strength hemostats, fibrin, and other sealants used on daily basis for medical procedures are presumed to hinder the growth. Stringent government norms on power devices in certain regions are expected have negative impact on the market growth over the forecast period. Due to side effects related with some medical tools making people think twice before using the device. Several inadequate product quality assurance concerns to performance related to this device, improper procedures in sterilization for used equipment affect the individual health which is further expected to reduce the industry growth. Lack of affirmative governing structure in some developing regions is presumed to act as restraints for the market expansion across the globe. Huge price competition among the industry participants is presumed to hamper the Industry growth. Emerging economies such as India and China are presumed to be an opportunity for the industry participants to enter in this untapped market.

Based on product type surgical equipment market is segmented into surgical handheld instruments, staples & electrosurgical devices and surgical sutures. The surgical handheld instruments are further segmented as retractors, scalpels, and scissors and forceps. Till 2012, surgical staples and sutures appeared as maximum revenue generating product in surgical equipment market across the world. But, electrosurgical instruments are presumed to witness pleasing growth over the six years period owing to the rise in demand for minimally invasive operating procedures that greatly use this equipment.

The market is classified as Neurosurgery, Wound Closure, Plastic and reconstructive surgeries, Urology, Thoracic surgery, Cardiovascular, Obstetrics and gynaecology, Orthopaedic surgery, Micro vascular, Laparoscopy and Others based on different applications. Under developed regions such as North America and Europe are amongst the regional market for this equipment. And under the developing regions Asia Pacific are the regional markets catering the demand for this instrument. North America appeared as the maximum revenue contributing regional market due to constant R&D initiatives along with technological innovation which is leading to the better products development. Thus this is expected to boost the regional market growth. Asia Pacific is expected to grow at a lucrative CAGR over the next six years due to increasing awareness and adaptation pertaining to the advanced surgical equipment. Rise in disposable income is expected to propel the market growth. Rise in disposable income in emerging economies such as India is presumed to compliment the increase in demand for surgical equipment market in this region.

To get free request sample :

https://www.millioninsights.com/industry-reports/circuit-breaker-fuse-relay-market/request-sample

Many companies are implementing strategies such as collaboration acquisitions, and expansions to hold a strong position in this industry. Surgical equipment market is highly cost intensive with huge investment cost. Industry participants are investing heavily on research and development to have competitive advantage. Product innovation and product introduction is the important strategy adapted in this industry. Prominent industry participants includeKLS martin group, Smith & Nephew PLC, Zimmer holdings Inc., Ethicon Inc., Carefusion Corporation, Alcon Laboratories Inc., Conmed Corporation and Stryker Corporation. Stryker, Carefusion and Zimmer are observed to dominate the industry for electrosurgical instruments in recent past.

Chemiluminiscence Imaging has a better playing field in developed economies

Chemiluminiscence Imaging or commonly known as CLIA is a doctrine predominantly witnessed in healthcare sector and blotting techniques and its relevance in detection of cancer has been well-documented. Chemiluminiscence transpires or better still molecules of light are emitted when luminol, synthetic compound (C8H7N302) reacts with an oxidizing agent viz hydrogen peroxide. Chemiluminiscence imaging marks its presence in forensic analysis by detecting traces of blood with iron content that emits a blue light under influence of an oxidizing agent or an oxidant.

Yet again, blue light emission states presence of copper cyanide and specific proteins as they come in contact under influence of an oxidant in an observed chemical reaction. Secondary equipment coming in handy is a HD camera for imaging. Chemiluminiscence also is used in biological assays to detect presence of biomolecules and traces of inorganic ions. Luminescence accepts various sequences as biochemical for bioluminescence, photons for photoluminescence and electromagnetic as electroluminescence based on excitation event.

Segmentation of chemiluminiscence imaging market by applications include chemiluminiscence immunoassays, hormones, insulin, thyroxin, estradiol, vitamin Vit 12, tumor markers, DNA hybridization detection, souther blotting, hybridization, western blotting, forensic science, food analysis, find organophosphorus most popular pesticide (Qunalphos).

Read full research report:

https://www.millioninsights.com/industry-reports/chemiluminiscence-imaging-market

Segmentation of chemiluminiscence market by region includes North America, Europe, Asia Pacific, MEA and Latin America. North America is foremost player in field of chemiluminescence imaging followed by Europe. The chemiluminiscence market is witnessing a high growth trajectory in North America and Asia pacific with established presence of big players in the field of chemiluminiscence imaging.

Chemiluminiscence is a highly fragmented market with too many players in contention, both local and international. Product launches such as Odyssey launched by LI-COR Biosciences and with uncluttered use in segments across industries such as biological and food analysis market drives growth in chemiluminiscence market. Drivers to the chemiluminiscence market include its preferential use in food, medical and forensic industry and in pre-clinical tests and R& D by research institutes and pharmaceutical laboratories.

Product development has wide scope in research and development laboratories using chemiluminiscence imaging enhancing growth in chemiluminiscence imaging market. As per industry news, chemiluminiscence immunoassays offer best solutions for quantification of low concentration of samples from an ambiguous mixture in comparison to RIA.

The non-radioactive nature of technique is better still in applications ranging from microbiology, Agriculture, therapeutic and clinical segments. CLIA has a better playing field in developed economies such as North America and Europe being a fully automated version. Key industry players in chemiluminiscence imaging market include LI-COR Biosciences, Analytik Jena US, Azure Biosystems, Berthold Technologies GmbH & Co., KG, Syngene, GE Healthcare, Thermo Fischer Scientific, Analytic Jena Life Science and PerkinElmer, Inc. 

Download free request sample:

https://www.millioninsights.com/industry-reports/chemiluminiscence-imaging-market/request-sample

Increasing presence of medical device companies that comply well with the pre-clinical studies in in-vivo experiments

Industry Insights

The global Preclinical Imaging Market size was worth USD 1.8 billion in 2015, which is anticipated to grow at a CAGR of more than 8.1% during the forecast period. Constant technological advancements and increasing expenditure on research and development are some of the leading factors for such huge market size with more and more pharmaceutical companies targeting this market. Similarly, rise in the number of contract research manufacturing and increasing presence of medical device companies that comply well with the pre-clinical studies in in-vivo experiments would further drive the market growth.

Use of various computerized database systems with advanced technology has increased over the years due to implementation of stringent laws and policies on animal testing which prevents exploitation of animals. Pre-clinical imaging has led to extraction of extremely detailed images of organs, cells, tissues and their anatomical features before and after the drug intake. Such methods of imaging along with micro-dosing, in-vitro tests have become an alternative for conventional methods.

Preclinical imaging systems include MRI, CT scan that is categorized under non-invasive techniques and possesses great potential to grow in the coming years. Some of the major factors that may challenge the acceleration of the market is increased cost, lack of skilled staff, underdeveloped infrastructure and non-availability such technically advanced devices in the third world countries.

Government bodies of developing countries such as Japan, Mexico, and Brazil, are making huge investments to spread awareness about the use of pre-clinical devices for research studies, and thereby focusing on quality and safety. Regions such as Latin America, Middle East and Asia Pacific are witnessing increase in foreign investments, which is leading to greater revenue generation, for the market growth.

Segment Insights

The optical imaging segment captured the largest market share in 2015 due to increased use of small animals in a number of animal research projects.

The fastest growth rate in the market was exhibited by multi-modal systems segment during the forecast period due to enhancement in integrated systems, which enable multiple screening in single device. It helps to achieve a detailed digital imaging of anatomical features for the organs of animals. A significant share of the market is being shared by the reagent segment, which showed higher frequency of purchases as compared to other segments.

Introduction of various features in imaging devices have resulted in increased number of applications. The development of various cancer therapies has benefitted from such up gradations in the technology, which makes it useful for numerous purposes. Other sectors, which have gained from the use pre-clinical imaging, includes obstetrics, gynaecology and cardiology.

Regional Insights

North America dominated the pre-clinical imaging industry capturing the largest revenue share in 2015, due to the fact that the region has maximum number of skilled workmen, developed infrastructure, higher acceptance and adoption of advanced technical devices and presence of large number of research projects which are being carried out.

In some regions including Canada, there have been various government initiatives and policies, which have helped in enhancement of research and development work in the form of funding and exemption from tax. All these factors can be attributed to conclude that North America will be a dominating region in this market, in terms of revenue.

Factors such as increased government funding, liberal government laws, growing adoption of contract research organisations, affordable research cost is contributing towards the highest CAGR of Asia Pacific region. .India and China are the key leaders in the Asia Pacific region, making it one of the most booming regions for the preclinical imaging market.

Competitive Insights

The global pre-clinical imaging market consists of international as well as local players. The capital required for the companies to enter in this market is comparatively lesser. The major players in this market are Siemens A.G., TriFoil Imaging, PerkinElmer, Inc., Mediso Ltd., General Electric(GE), Bruker Corporation, VisualSonics Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.

A huge pool of companies is focused towards advancing in the pre-clinical imaging market after thorough research and development in this sector. The most common strategy opted by companies are through mergers acquisitions and collaboration in order to gain maximum share in the market.

Read full research report:

https://www.millioninsights.com/industry-reports/preclinical-imaging-market

Download free request sample:

https://www.millioninsights.com/industry-reports/preclinical-imaging-market/request-sample

Gas exchange support and hemodynamic support is provided by the veno-arterial ECMO system

Industry Insights

The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period. The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.

According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S. In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.

Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD. ECMO machines are gaining popularity in the hospital and healthcare systems due to the rising trend of its application during cases of respiratory disorders.

The ECMO machines are used in cases of cardiac failure to facilitate auxiliary oxygen support system. These machines are frequently used in patients suffering from respiratory conditions and also in neonates and pediatric patients. The estimated growth of these machines can be attributed to the critical nature of the target population consisting of neonates and pediatric patients.

Modality Insights

The segmentation of the key modalities is done on the basis of the different setups that are provided by the ECMO circuit such as arterio-venous, veno-arterial and veno-venous. They are used to provide hemodynamic support and to facilitate gaseous exchange in patients with cardiac or respiratory failure.

Both gas exchange support and hemodynamic support is provided by the veno-arterial ECMO system. It majorly works by passing the blood flow from the patients’ heart and lungs to the ECMO circuit. The veno-venous ECMO system on the other hand facilitates sole gas exchange support in which the blood is made to return to the heart prior to pulmonary circulation. According to the U.S. National Institute of Health (NIH), combination of veno-venous and veno-arterial is used in specific cases such as cardiogenic shock.

Applications Insights

As per applications, the market is segmented into Extracorporeal Cardiopulmonary Resuscitation (ECPR), respiratory and cardiac. The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric. The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.

The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders. As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.

Regional Insights

The major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA. North America has grown considerably in this segment majorly attributed to the well developed primary, secondary and tertiary care hospitals combined with the reimbursement network, increasing awareness about the ECMO system facilitating their rapid adoption in the hospitals and favorable government funding.

Refinements in the technology presently in use was made by Terumo Cardiovascular Systems Corporation during the production of CAPIOX FX Oxygenator. This system is expected tohelp in increasing the blood rate and offer complete control over the entire process.

Competitive Market Share Insights

Some key players operating in the ECMO market include MAQUET Holding B. V. & Co. KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group, Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and Nipro Medical Corporation. The major strategic initiatives adopted by the companies in this vertical are technological advancements in the existing portfolio and new product development.

For example, Medtronic Plc designed Minimax Plus Oxygen System for patients from wide ranging age groups such as from neonates to children, with features such as venous air director and low arterial port, which are integrated in the system to increase the safety levels and performance.

Read full research report:

https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market

Download free request sample:

https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market/request-sample

Global bone densitometers is predicted to grow with a CAGR of 3.9% during the forecast period

Industry Insights

The market size of global bone densitometers was worth USD 893.7 million in the year 2016 and is predicted to grow with a CAGR of 3.9% during the forecast period. The significant increase in prevalence of osteoporosis on global level is the major driving force. This has led to an upsurge in demand for efficient assessment with the use of bone densitometers. In addition, the increase in geriatric population base, which is more susceptible to metabolic bone diseases, is expected to provide lucrative growth opportunities.

The rise in osteoporosis incidence in menopausal women is anticipated to be a key growth contributor. According to International osteoporosis foundation, over 200 million females are suffering from this disease globally with 1/10th belonging to 60 years, 2/5th in 80 years’ group, 1/5th in 70 years and 2/3rd in 90 years’ age group. Moreover, every 1 out of 3 women above the age of 50 years were seen to suffer from fragility fractures once in their lifetime.

According to a report published by National Institutes of Health Osteoporosis and Related Bone Diseases, various lifestyle-related factors including smoking, alcohol abuse and sedentary lifestyle are major contributors for development of osteoporosis in males. The above mentioned factors provide a clinical urgency to reduce this disease burden and hence fuel the rate of adoption of these assessment devices to suffice early diagnosis.

Additionally, advent of technologically advanced products such as ultrasound & computer assisted densitometers and integrated digital detectors cater to the needs of technicians and physicians by reducing measurement time and facilitating easy operations. The use of ultrasound based densitometers has increased to wide range of fields including endocrinology, gynecology and various others.

Browse full research report:

https://www.millioninsights.com/industry-reports/bone-densitometers-market

Furthermore, the increase in demand for these devices can be attributed to the collaborative initiatives undertaken by key companies for research and development of new products to enhance the diagnostic tools for advanced skeletal assessment. Also, funds for research by various healthcare organizations for development of technologically advanced products are also projected to drive the market. For instance, Lunar Expert developed by GE Healthcare provides spatial resolution leading to enhanced risk assessment and identification via advanced visualization.

Technology Insights

The largest share in the technology segment was held by axial bone densitometers with over 60.0% in 2016 as a consequence of consistent adoption rate of these devices. The fulfillment of various requirements and needs of clinicians by usage of these devices can be attributed to the increasing penetration rate of the technology. These majorly include the central dual energy x-ray absorptiometry, technology based tools which are crucial for accurate diagnostic results.

Moreover, the usage of these bone assessment devices are predicted to be a result of enhanced precision, sensitivity, optimum linearity leading to reduced variation in diagnostic performance. The above mentioned factors along with their cost effective nature are responsible for the high adoption of these by clinicians.

End-use Insights

The major share was held by hospitals in 2016 owing to the large volume of patients and frequent readmission. Moreover, sophisticated infrastructure facilitating high efficiency of diagnostic procedures with bone assessment devices is expected to drive the hospital segment.

The rise in initiatives by healthcare organizations to promote technologically advanced and sophisticated instruments for rapid result generation also serves as a key growth driving factor. In addition, hospitals in present scenario are using totally automated systems having the ability for assessment of conditions at an early stage. The aforementioned factors are predicted to positively impact the segment growth during the forecast period.

Regional Insights

The market was dominated by North American region in 2016 owing to the rising osteoporosis burden of the region. Various strategic initiatives by prominent market players for improvement of R&D capabilities and maintaining high medical standards are anticipated to drive the regional demand.

The growth across Asia Pacific region is expected to be exponential throughout the forecast period with a CAGR of xx%. The high growth can be attributed to the rise in demand to reduce the existing prevalence, increased disposable income and improvements is infrastructure of healthcare facilities. The developing economies including China and India presents a potential growth opportunity in the forecast period owing to the high awareness level related to osteoporosis care.

Competitive Insights

The intensive competition in the industry is expected to rise throughout the forecast period as a consequence of increasing number of strategic initiatives such as new product development, R&D investments, acquisitions and mergers by prominent market players to maintain their competitive edge over the other companies.

For example, Hologic, Inc. in August 2014 received regulatory approval for horizon DXA platform in Canada having workflow efficiencies and enhanced technical capabilities. The integrated ceramic detector array and high resolution achieved by the devices helps in enhanced stability, precision, image quality and skeletal mapping.

To get free request sample:

https://www.millioninsights.com/industry-reports/bone-densitometers-market/request-sample

Ambulatory services industry include increasing preference for minimally invasive surgeries

The global Ambulatory Services Market is expected to grow at a CAGR of 6.1% in the upcoming period. This could be credited to an ever-increasing preference for OPD (out patient department). Moreover, outpatient care does prove to be cost-effective. On an additional note, governments across the globe have been taking initiatives to lend monetary support to ambulatory healthcare facilities.

The other factors driving the ambulatory services industry include increasing preference for minimally invasive surgeries along with technological advancements. For example – development of endoscopy and laparoscopy has lessened the requirement for prolonged hospital stays. The U.S. witnessed inauguration of CDI (Methodist Center for Diagnostic Imaging) in Dec 2016. It comes across as one of the outpatient-based imaging centers delivering pocket-friendly and high quality medical imaging to the patients.

On the similar grounds, NHS did introduce reforms in Feb 2016; which paved the way for providing extra funding to the general physicians so as to simplify the formalities related to emergency and casualty departments. This has bolstered prospects of PHP (Primary Healthcare Properties).

The ambulatory services market is segmented by type and geography. By type, the segmentation goes like primary care offices, emergency departments, surgical specialty (ophthalmology, orthopedics, gastroenterology, pain managements/spinal injections, plastic surgery, and others), and medical specialty. By geography, the market spans North America (Canada, U.S.), Europe (Belgium, The Netherlands, Switzerland, Italy, Spain, France, Germany, and UK), Asia Pacific (South Korea, Thailand, Australia, India, China, and Japan), LATAM (Columbia, Mexico, and Brazil), and MEA (South Africa, Saudi Arabia, and UAE).

The business strategies adopted by players include new product launches, mergers and acquisitions, and geographic expansion. For instance – at the beginning of the year 2015, Indian government did announce its plan of increasing healthcare spending to 2.5% of GDP. “Aayushmaan” yojana is a part and parcel of this initiative.

North America rules the market due to excessive attention being paid to healthcare by the government of the U.S. Europe comes in second. This could be attributed to Denmark and Belgium being healthcare capitals. Asia Pacific is expected to grow at the fastest pace due to above-mentioned measures taken by Indian government.

The players contributing to the ambulatory services market include Medical Facilities Corporation; Aspen Healthcare; Terveystalo; and IntegraMed America, Inc. In Jan 2017, AmSurg Corp. and Envision Healthcare together acquired “Emergency Professional Services, PC”. This acquisition is inclusive of a neonatal group, a radiology group, an emergency medical group, and two anesthesia groups.

Read full research report:

https://www.millioninsights.com/industry-reports/ambulatory-services-market

Download free request sample:

https://www.millioninsights.com/industry-reports/ambulatory-services-market/request-sample

Rising demand for surgical procedures owing to growing prevalence of chronic diseases

The global Medical Specialty Bags Market is anticipated to exhibit a healthy CAGR during the forecast period, according to a report available on Million Insights. Medical specialty bags are uniquely designed bags that are used for various medical purposes such as blood storage, bile collection, urine collection, enteral feeding, and sterile packaging. Almost all healthcare facilities use these collectors on regular basis to protect patients and medical staff from infection. Every day, healthcare facilities such as hospitals and clinics generate tons of medical waste such as used syringes and blood socked cotton. Exposure to such medical waste can infect week patients and doctor present in healthcare facilities. Thereby, it is essential for medical facilities to use specialty bags.

Rising demand for surgical procedures owing to growing prevalence of chronic diseases is expected to impel medical specialty bags industry growth. Medical procedures such as blood transfusion and dialysis require huge amount of specifically designed bags. In addition, growing adoption of ostomy procedures to treat diverticulitis, inflammatory bowel disease (IBD), and colorectal cancer is driving demand market growth. Rising demand for environment-friendly to reduce amount of disposal during surgical procedures is anticipated to propel medical specialty bags market growth. Manufacturers are offering biodegradable and flushable pouch liners to ensure safety caregiver and patients. Moreover, supportive initiatives being taken by government and private organizations to promote use of eco-friendly medical disposables will drive the medical specialty bags industry over the forecast period.

To cater to rising demand for special bags, manufacturers are investing in R&D to develop innovative products. For instance, in May 2018, Punjab Pollution Control Board (PPCB) in India launched compostable bags for storage and disposal of biomedical waste in hospitals. The organization distributed these eco-friendly waste collectors to multiple hospitals in the state for trial. According to feedback received from the hospitals, bags are found to be strong and durable.

Browse full research report:

https://www.millioninsights.com/industry-reports/medical-specialty-bags-market

Product Insights:

Based on product, the medical specialty bags market is categorized into resuscitation bags, anesthesia, bile collection, sterile packaging, blood, intravenous, cadaver, enteral feeding, ostomy collection, enema, and continuous ambulatory peritoneal dialysis (CAPD). Ostomy collection segment is anticipated to dominate and account for largest market share over the forecast period. This is attributed to rising cases of IBD and colorectal cancer. In addition, growing geriatric population and rising health awareness is driving segment’s growth.

Disposable intravenous pouches are also getting popular among healthcare facilities owing to benefits such as effectiveness and biodegradability. Growing focus on use of eco-friendly materials will drive segment’s growth.

Application Insights:

On the basis of application, the medical specialty bags industry is classified into hospitals, healthcare institutes, surgical centers, and home healthcare. Surgical centers segment is expected to hold significant market share in the coming years. This is attributed to growing adoption of surgical procedures to get instant relief from pain. Intravenous fluid bags are used various applications including IV volumes hypovolemic state in patients and balancing the basal hydration level. In addition, they are used in medical procedures with convenience and ease to provide nutrition to patients.

Regional Insights:

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. North America is predicted to dominate and likely to account for largest market share over the forecast period. Supportive reimbursement policies and established healthcare infrastructure are driving regional market.

Europe, on the other hand, is expected to follow North America in terms of market share during next few years. Growing adoption of surgical procedures such as laparoscopy along with rising healthcare expenditure will drive demand for effective medical bags. Asia Pacific is anticipated to witness significant growth rate over the forecast period owing to government initiatives, rising population, and growing economies.

Some of the key players in the medical specialty bags market are Terumo Corporation, Coloplast A/S, Hollister Incorporated, Nolato AB, and Macopharma SA. Most companies are adopting business strategies such as merger and acquisition to expand their business portfolio. In addition, companies are using sophisticated tools and superior technology to develop quality products and to gain competitive edge over others.

To get free request sample:

https://www.millioninsights.com/industry-reports/medical-specialty-bags-market/request-sample

Key players of medical device outsourcing market are Wuxi Apptec, Integer, Freyr Solutions, Tecomet, PPD, Jabil, MAPI, Flextronics

Global Medical Device Outsourcing Market size is anticipated to reach USD 194.9 billion by 2025, with a healthy CAGR of 10.9% during the forecast period as the scope and its applications are rising enormously across the globe. Medical device outsourcing is a process of contracting a third party for several business purposes like supply chain management, manufacturing, prototyping, and product designing.

The factors that are playing a major role in the growth of medical device outsourcing market are the growing occurrence of disorders, growing geriatric population, the rising use of enhanced technology, and the high demand for medical devices from end-users. However, issues related to the reimbursement policy and risk of loss of private information may restrain overall market growth in the years to come. Medical device outsourcing market is segmented based on service, therapeutic area, and region.

In-Depth research report on Medical Device Outsourcing market:

https://www.millioninsights.com/industry-reports/medical-device-outsourcing-market

Contract manufacturing, quality assurance, product maintenance services, regulatory affairs services, product upgrade services, product design and development services, product implementation services, and product testing & sterilization services are the services that could be explored in medical device outsourcing in the forecast period.

Contract manufacturing sector comprises device, accessories, component, and assembly manufacturing. Regulatory affairs services sector comprise legal representation, clinical trials and product registrations, regulatory writing and publishing, and others. Product design and development services sector comprises packaging, designing & engineering, molding, and machining. The contract manufacturing sector accounted for the significant market share of medical device outsourcing and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be a reduction in the cost of production.

Browse reports of similar category available:

https://www.millioninsights.com/industry/medical-devices

Based on therapeutic area, diabetes care, dental, general and plastic surgery, IVD, diagnostic imaging, endoscopy, drug delivery, ophthalmic, orthopedic, cardiology, and others could classify medical device outsourcing in the forecast period. The cardiology sector accounted for the substantial market share of medical device outsourcing and is estimated to continue its dominance in the years to come. The reason could be the growing number of patients suffering from associated conditions. Also, general and plastic surgery sector is estimated to grow at the fastest pace in the years to come.

Globally, Asia Pacific accounted for the substantial market share of medical device outsourcing and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in the region, growing number of patients suffering from chronic diseases, the developing R&D and manufacturing set up, and low labor cost. The developing countries like India and China are the major consumers of medical device outsourcing in this region.

North America and Europe are also estimated to have a positive influence on future growth. North America is the second largest region with significant market share. However, Europe is estimated to grow at the highest CAGR in the forecast period. The key players of medical device outsourcing market are Wuxi Apptec, Integer, Freyr Solutions, Tecomet, PPD, Jabil, MAPI, Flextronics, Intertek Group, Celestica, Pace Analytical Services, Sanmina, Eurofins Scientific, Plexus, Toxikon Inc., and SGS SA. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.

To get free request sample:

https://www.millioninsights.com/industry-reports/medical-device-outsourcing-market/request-sample

Medical ultrasound collects information about biological medium

The global Ultrasound Devices Market is set to witness a higher CAGR for the forecast period. Medical ultrasound represents images showing part of the body that are called as tomographic images. It collects information about biological medium without any modification. Ultrasound is thus a sound higher above 20Hz to 20kHz. For propagation, it needs a medium, by which it can propagate by means of deformation of medium. A medium is made of small spheres connected with springs.

Commercially, the use of ultrasonography in medical practice has been on constant evolution in the last few decades and continues to evolve as technological advances are fused with daily medical practice. The drivers for ultrasound device market entail rise in birth rate and in-vitro fertilization treatment coupled with rise in demand for sonography devices. Additionally, the market registers a rapid rise in number of new cases diagnosed with breast cancer. Presence of health agencies and government institutions are possibly to stimulate the global market scenario.

Ultrasound devices market is segmented as non-woven and knitted woven, based on raw material. Application segment for ultrasound device industry involves healthcare & hygiene, implantable good and non-implantable goods. Geographical segmentation for ultrasound device market comprises North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America dominates the global scenario due to the presence of a robust healthcare infrastructure and inclination towards home healthcare and rise in customer pool. APAC market is highly competitive due to the presence of large players. Untapped potential and lucrative opportunities in emerging economies reveal some excellent growth scenarios in the APAC sector.

The key players in the ultrasound devices industry include Toshiba Medical Systems Corporation, Philips Healthcare, Siemens Healthcare, Hitachi Medical Corporation, Samsung Medison, Mindray Medical International Limited, Analogic Corporation, GE Healthcare, Philips Healthcare and SonaCareMedical.

Read full research report:

https://www.millioninsights.com/industry-reports/ultrasound-devices-market

Download free request sample:

https://www.millioninsights.com/industry-reports/ultrasound-devices-market/request-sample

Increase in geriatric population and prevalence of cardiac disorders

Global Bioprosthetics Market is estimated to reach USD 6.41 billion by 2024 due to increase in geriatric population and prevalence of cardiac disorders. Bioprosthetics are the heart valves which are used in clinical practices. They are acquired due to medical implantations or animal tissue. Over the years, bioprosthetics has advanced in the domain. Bioprosthetics not only repair the injured area but also the regenerate sufficiently organized tissue that support angiogenesis and recruit growth factors obtaining the same characteristics of the healthy tissues.

The factors driving bioprosthetics market are the growing prevalence of rheumatoid heart disorder, cardiac disorders and peripheral artery disorders and consistent demand for medications. The bioprosthetics products are made of biological materials, where the rejection rate in implants is less than as compared to the synthetic implants.

Moreover, the increasing geriatric population with cardiac disorders is stimulating the growth of bioprosthetics industry. However, the growing need for numerous procedures, threat of incompatibility and contaminations (rejection of tissues), irreparable nature and risk of irregular skin tone and after surgery scars are hampering the growth of the market.

Browse full research report:

https://www.millioninsights.com/industry-reports/bioprosthetics-market

Bioprosthetics market is experiencing emergence of new technologies in the field of hybrid tissue-engineered bioprostheses, which uses non-biodegradable cultured tissue scaffolds. These tissues are highly resistant, durable and can be replaced with biodegradable tissue-engineered prosthetics. This technology helps the patients recover and lead a normal life ultimately boosting the market of bioprosthetics in the years to come.

Bioprosthetics industry is categorized on the basis of type, application, and geography. On the basis of type, application, and geography. On the basis of type, the market is divided into allograft, bovine, porcine, and xenograft. Allograft segment is expected to hold larger share due to several benefits like smaller incisions, physiological acceptance, less surgical time, and safer alternative to surgeries.

In terms of application, bioprosthetics is split into cardiovascular, plastic surgery, and wound healing. Wound healing and plastic surgery segments are projected to lead bioprosthetics market owing to the rising number of soft tissue repair surgeries. Geographically, bioprosthetics industry is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East& Africa. Europe is predicted to dominate the market of bioprosthetics owing to several demographic trends like increasing geriatric population, changes in lifestyle, frequent approvals of products, and growing awareness.

The major players in bioprosthetics industry are BraileBiomedica, Inc., Aortech International Plc, Edwards Lifesciences Corporation, St. Jude Medical, Inc., Organogenesis, Inc., LeMaitre Vascular, Inc., CryoLife, Inc., Life Cell Corporation, LabcorLaboratorios Ltd., Medtronic Plc., Humacyte, Inc., MaquetMetinge Group, Sorin Group, Ethicon, Inc., JenaValve Technology GmbH among others.

To get free request sample:

https://www.millioninsights.com/industry-reports/bioprosthetics-market/request-sample

Cardiovascular devices are available with respect to different heart disorders

Global Cardiovascular Devices Market is anticipated to grow significantly in the forecast period owing to the changing lifestyle and prevalence of chronic disorders associated with the heart. Cardiovascular devices diagnose and treat heart disorders and related health issues. Several types of cardiovascular devices are available with respect to different heart disorders. The majorly used devices are endovascular grafts, coronary stents, artificial heart valves, and angioplasty balloon catheters.

The demand for cardiovascular devices is majorly driven by the rising prevalence of heart-related issues, which ultimately stimulates cardiovascular devices industry. Also, growing demand for minimally invasive procedures benefit patients with less pain, reduced chances of infections, less period of hospital stay, and speedy recovery from disorders are the advantages faced by patients. These advantages along with growing number of conditions like diabetes, obesity are encouraging the growth of cardiovascular devices market.

In-Depth research report on Cardiovascular Devices market:

https://www.millioninsights.com/industry-reports/cardiovascular-devices-market

Moreover, technical modernizations in cardiac devices are expected to have stronger impacts on cardiovascular devices industry in the near future. However, strict legislations and protocols, significant cost of devices and lack of skilled healthcare staff is majorly obstructing cardiovascular device market. The market is witnessing trends like increasing mergers & acquisitions (manufacturing companies of cardiovascular devices) and speedy product launches.

Cardiovascular devices industry is categorized on the basis of product type and geography. On the basis of product type, the market is divided into electrophysiology devices, cardiac diagnostics & monitoring devices, interventional cardiac devices, peripheral vascular devices, cardiac prosthetic devices, cardiac rhythm management (CRM), etc. Cardiac diagnostics and monitoring segment is expected to hold larger share owing to cardiac rhythm management, portability and compact design.

Geographically, cardiovascular devices market is segmented as North America, Europe, Asia Pacific, and Middle East & Africa. North America leads the market owing to increasing investment and developed healthcare infrastructure. The key players in cardiovascular device industry include Abbott Vascular, Aboimed, Inc., Biotronik SE & Co. KG, Johnson & Johnson, B. Braun Melsungen AG, Cordis Corporation, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., GE Healthcare, among others.

To get free request sample :

https://www.millioninsights.com/industry-reports/cardiovascular-devices-market/request-sample